CFCG is committed to upholding good corporate governance practices in all aspects of business and procedure in safeguarding shareholders’ interests to ensure that all aspects of business are conducted in accordance with all applicable laws and regulations.
The Audit Committee is to review and supervise the financial reporting process, financial controls, internal control and risk management system of the Group and to provide recommendations and advices to the Board on the appointment, re-appointment and removal of external auditors as well as their terms of appointment.
Members: Mr. CHU Kin Wang, Peleus (Chairman) Dr. LI Zhiqiang Mr. Wang Song
The major function of the Remuneration Committee is to make recommendation to the Board on the remuneration policy and remuneration structure for all Directors of the Company.
Members: Mr. Wang Song (Chairman) Mr. ZHAO Zhijun Mr. CHU Kin Wang, Peleus
The major function of the Nomination Committee is to review the structure, size and composition of the Board, identify individuals suitably qualified to become members of the Board, and assess the independence of independent non-executive directors.
Members: Dr. Wilson SEA (Chairman) Mr. CHU Kin Wang, Peleus Mr. Wang Song
The Strategy Committee is to adopt to needs of the strategic development of the Company, enhance the core competitiveness of the Company, ensure the development plans of the Company, improve the investment decision form, strengthen the scientific decision-making, uplifting the efficiency in investment decisions and quality of decisions and optimize the management structure of the Company.
Members: Dr. Wilson SEA (Chairman) Dr. Zhu Huanqiang Mr. ZHAO Zhijun Dr. LI Zhiqiang Mr. Wang Song
Risk Management Committee
The Risk Management Committee is responsible for assisting the Board in deciding the risk level and risk appetite of the Group and considering the Company’s risk management, intern al control systems, environmental, social and governance (“ESG”) strategies and provides directions where appropriate.
Members: Dr. Wilson SEA (Chairman) Dr. Zhu Huanqiang Mr. CHU Kin Wang, Peleus